Antimicrobial Resistance: Close the Over-the-Counter Tap Before Resistance Outruns the Drug Pipeline

Diagnosis

Antimicrobial resistance is a tier-1, structural health threat for Bangladesh, and the curated characterization points to three reinforcing drivers: over-the-counter (OTC) antibiotic sales, resistance in pediatric use, and resistance in poultry. These are not separate problems. They are one feedback loop. When antibiotics can be bought without a prescription, courses are under-dosed, cut short, or wrong for the infection, and each misuse selects for resistant organisms. The same pressure plays out in poultry, where routine non-therapeutic antibiotic use moves resistant bacteria into the food chain and back to people. Pediatric resistance is the early warning siren: when the youngest patients no longer respond to first-line drugs, the country is already paying the cost in longer illnesses, more hospital days, and a shrinking shelf of effective medicines.

What makes this urgent is its irreversibility. Unlike a budget gap that can be closed next fiscal year, lost antibiotic effectiveness does not return on a policy cycle. Every month of unchecked OTC dispensing narrows future options, and the replacement drug pipeline is slow and expensive. The lead responsible body is the Directorate General of Health Services (DGHS), with the Department of Public Health Engineering as a supporting body on the water and sanitation pathways that spread resistant organisms.

Recommended actions

1. Enforce prescription-only dispensing at the pharmacy counter. Owner: DGHS. Mechanism: a DGHS circular binding licensed pharmacies to a prescription requirement for systemic antibiotics, paired with drug-inspector spot audits and license conditions tied to compliance. Observable signal: a rising share of audited pharmacies that record a prescription before sale, and falling counter-sales of antibiotics without one.
2. Stand up a national AMR surveillance backbone. Owner: DGHS. Mechanism: designate sentinel hospital laboratories to report standardized antibiotic-susceptibility data into a central DGHS register, prioritizing pediatric wards where resistance shows first. Observable signal: a growing number of reporting sentinel sites and the first published national resistance profile for priority pathogens.
3. Curb non-therapeutic antibiotic use in poultry. Owner: DGHS, coordinating with the livestock and food-safety authorities. Mechanism: a joint directive phasing out antibiotics as growth promoters and restricting human-critical drug classes in poultry, enforced through feed-mill and farm licensing. Observable signal: declining sales of growth-promoter antibiotic feed additives and resistant-organism detection in poultry sampling.
4. Run a prescriber and public stewardship programme. Owner: DGHS. Mechanism: standard treatment guidelines distributed to clinicians plus a sustained public campaign on completing courses and not self-medicating. Observable signal: measured uptake of guideline-concordant prescribing at facility audits.
5. Cut environmental transmission. Owner: Department of Public Health Engineering, supporting DGHS. Mechanism: target water and sanitation upgrades around health facilities and dense settlements where resistant organisms circulate. Observable signal: improved sanitation coverage at priority sites.

Sequencing (first 12 months)

Start with the OTC tap (action 1) and surveillance (action 2) together. Enforcement is the fastest lever DGHS controls directly, and surveillance is what proves it is working and tells you where resistance is worst. These two unlock everything else: the data justifies the poultry directive (action 3) and targets the stewardship campaign (action 4). Environmental work (action 5) is a longer build and should begin in parallel but is judged over multiple years.

Risks and constraints

The binding constraint is enforcement capacity, not policy design. A prescription-only rule is only as strong as the inspector network behind it, and pharmacies have a commercial incentive to keep selling. The poultry restriction faces a farm-economics constraint: producers rely on cheap antibiotics, so a phase-out without an alternative husbandry path invites evasion. Surveillance depends on functioning laboratories and consistent reporting, which is a staffing and budget question. Each action must therefore come with a funded enforcement and laboratory line, or it becomes a paper rule.

Bottom line

Bangladesh is spending down a non-renewable asset, the effectiveness of its antibiotics, and the OTC counter is where that spending is fastest and most preventable. DGHS should lead with prescription enforcement and surveillance now, because the cost of resistance is paid first by children and cannot be reversed once the last-line drugs fail.